Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
Conditions
- Diabetes Mellitus, Type 2
- Diabetes Mellitus Type 2 With Proteinuria
- Diabetes Mellitus
- Diabetes
- Diabetes Complications
- Albuminuria
- Chronic Kidney Diseases
- Chronic Kidney Disease Due to Type 2 Diabetes Mellitus
- CKD
- Proteinuria
Interventions
- DRUG: Dapagliflozin 10mg Tab
- DRUG: Placebo
- DEVICE: Withings BPM Connect
- DEVICE: Withings Body+
- DIAGNOSTIC_TEST: Hem-Col Capillary Blood Collection Device
- DEVICE: MEMS (Medication Electronic Monitoring System) Cap
- BEHAVIORAL: Questionnaire: participants' perspectives toward remote data collection
Sponsor
University Medical Center Groningen
Collaborators